Company Overview and News

0
FinMin seeks more time for PSBs to meet MPS norm

2018-07-16 freepressjournal.in
New Delhi : The finance ministry may approach markets regulator Sebi to seek relaxation on the minimum 25 per cent public shareholding norm for some state banks (PSBs).
INDIANB IOB 500116 UDBKL IDBI UBLS 532418 532814 532505 CNRYY 532388 SYNDIBANK 532276 532121 532483 UBLA UCOBANK CANBK DENABANK ANDHRABANK

0
UCO Bank - Updates

2018-07-13 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
532505 UCOBANK

0
PSU banks plan to raise over Rs 50k crore equity capital in FY19

2018-07-08 moneycontrol
Public sector banks are planning to tap the markets to raise more than Rs 50,000 crore this fiscal to shore up their capital base for business growth and meeting regulatory global risk norms.
ALBK 532505 CNRYY 532179 SYNDIBANK 532276 532121 532483 CRPKY 532480 CORPBANK UCOBANK CANBK DENABANK

0
Liberty House’s resolution plan for Adhunik, Zion gets lenders’ nod

2018-07-05 livemint
Mumbai: The UK-based Liberty House on Thursday said its resolution plan for Adhunik Metaliks Ltd and its sister concern Zion Steel Ltd has received overwhelming voting support from lenders to the two companies. Liberty House was the sole bidder for the stressed asset.
AMKD IBN 532727 ALBK AMTEKAUTO 532505 ICICIBANK ABGSHIP 532682 PNJZY 532461 532174 532480 ADHUNIK PNB UCOBANK 520077 SBAZ

0
UK court grants enforcement order in Mallya assets case

2018-07-05 moneycontrol
A UK High Court judge has issued an enforcement order in favour of a consortium of 13 Indian banks, seeking to recover funds owed to them by beleaguered liquor baron Vijay Mallya who is fighting extradition to India on fraud and money laundering charges worth nearly Rs 9,000 crore.
IOB 500116 500469 UDBKL IDBI UBLS FDBAY 532505 FEDA 532388 PNJZY 532461 UBLA FEDS PNB UCOBANK FEDERALBNK SBAZ

0
Vijay Mallya’s London house can be searched, says UK High Court

2018-07-05 livemint
London: A UK High Court judge has issued an enforcement order in favour of a consortium of 13 Indian banks, seeking to recover funds owed to them by beleaguered liquor baron Vijay Mallya who is fighting extradition to India on fraud and money laundering charges worth nearly ₹ 9,000 crore.
IOB 500116 500469 UDBKL IDBI UBLS FDBAY 532505 FEDA 532388 PNJZY 532461 UBLA FEDS PNB UCOBANK FEDERALBNK SBAZ

2
UCO Bank, Allahabad Bank look to make recoveries this fiscal

2018-06-27 livemint
Kolkata: Two troubled lenders, UCO Bank and Allahabad Bank, on Wednesday told shareholders at their annual general meetings that they are looking to recover ₹4,000 crore and ₹5,500 crore, respectively, from troubled assets in the current year.
ESL BHUSANSTL ALBK 532505 533264 513216 UTTAMSTL PNJZY 532461 521070 ALOKTEXT 532480 PNB UCOBANK 500055

1
Allahabad Bank hopes to come out of PCA in 2020

2018-06-27 moneycontrol
State-owned lender Allahabad Bank is targeting to come out of the prompt corrective action (PCA), imposed on it by the Reserve Bank of India in the wake of the deterioration of its health, by 2020, a top bank official said.
ESL 521070 ALOKTEXT 532480 ALBK 532505 533264 UCOBANK

1
All Bank hopes to come out of PCA in 2020

2018-06-27 freepressjournal.in
Kolkata: State-owned lender Allahabad Bank is targeting to come out of the prompt corrective action (PCA), imposed on it by the Reserve Bank of India in the wake of the deterioration of its health, by 2020, a top bank official said. The bank, whose gross NPA stood at Rs 26,562.76 crore at the end of March 2017-18, is hoping to recover around Rs 5,500 crore in the current fiscal, UCO Bank executive director N K Sahoo said at the sidelines of Allahabad Bank’s AGM here today.
ESL 521070 ALOKTEXT 532480 ALBK 532505 533264 UCOBANK

0
UCO Bank - Shareholders meeting

2018-06-27 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
532505 UCOBANK

0
UCO Bank - Shareholders meeting

2018-06-27 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
532505 UCOBANK

3
NPA-hit PSBs aim to get out of RBI watchlist by ’20

2018-06-27 freepressjournal.in
New Delhi : Eleven public sector banks that are under the RBI’s watchlist for mounting bad loans on Tuesday expressed confidence before a parliamentary committee that they would emerge out of the central bank’s Prompt Corrective Action (PCA) framework by 2020, sources said.
IOB 500116 UDBKL IDBI ALBK UBLS 532505 532179 532388 532121 CRPKY UBLA 532480 CORPBANK UCOBANK DENABANK

3
11 heads to appear before parliamentary panel tomorrow

2018-06-25 freepressjournal.in
New Delhi: Heads of 11 state-owned banks will apprise a parliamentary committee of the problems of mounting bad loans and increasing fraud cases on Tuesday, sources said.
IOB 500116 UDBKL IDBI ALBK UBLS 532505 532179 532388 532121 CRPKY UBLA 532480 CORPBANK UCOBANK DENABANK

3
34 vie for MD post in PSBs

2018-06-25 freepressjournal.in
New Delhi : After completing the selection of executive directors, the Banks Board Bureau (BBB) will next week begin the process for identifying suitable candidates for the post of managing directors (MDs) in nearly a dozen state-owned banks.
INDIANB UDBKL ALBK 532418 UBLS 532814 532505 CNRYY SYNDIBANK 532276 532121 532483 UBLA 532480 UCOBANK CANBK DENABANK ANDHRABANK SBAZ

10
Heads of 11-PSBs to appear before par panel on Tuesday

2018-06-24 moneycontrol
Heads of 11-state-owned banks will apprise a parliamentary committee about the problems of mounting bad loans and increasing fraud cases on Tuesday, sources said.
FISI IOB 500116 UDBKL IDBI ALBK UBLS 532505 FIISO FIISP 532179 532388 532121 CRPKY UBLA 532480 CORPBANK UCOBANK DENABANK

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...